Movano Inc. (NASDAQ:MOVE) Short Interest Update

Movano Inc. (NASDAQ:MOVEGet Free Report) was the recipient of a significant increase in short interest in January. As of January 30th, there was short interest totaling 105,116 shares, an increase of 313.2% from the January 15th total of 25,442 shares. Currently, 12.9% of the shares of the stock are short sold. Based on an average daily volume of 5,519,052 shares, the short-interest ratio is presently 0.0 days. Based on an average daily volume of 5,519,052 shares, the short-interest ratio is presently 0.0 days. Currently, 12.9% of the shares of the stock are short sold.

Insider Transactions at Movano

In other Movano news, CEO John Mastrototaro sold 33,069 shares of the firm’s stock in a transaction dated Tuesday, January 27th. The stock was sold at an average price of $20.80, for a total transaction of $687,835.20. Following the sale, the chief executive officer directly owned 56,114 shares of the company’s stock, valued at $1,167,171.20. This trade represents a 37.08% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CTO Michael Aaron Leabman sold 6,845 shares of the business’s stock in a transaction dated Wednesday, January 14th. The shares were sold at an average price of $6.66, for a total value of $45,587.70. Following the completion of the transaction, the chief technology officer owned 22,639 shares in the company, valued at $150,775.74. The trade was a 23.22% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 94,383 shares of company stock valued at $1,524,933 over the last three months. Corporate insiders own 10.40% of the company’s stock.

Hedge Funds Weigh In On Movano

An institutional investor recently bought a new position in Movano stock. Citadel Advisors LLC purchased a new position in Movano Inc. (NASDAQ:MOVEFree Report) in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 49,262 shares of the technology company’s stock, valued at approximately $28,000. Citadel Advisors LLC owned about 5.94% of Movano as of its most recent SEC filing. Hedge funds and other institutional investors own 16.64% of the company’s stock.

Trending Headlines about Movano

Here are the key news stories impacting Movano this week:

  • Positive Sentiment: Movano’s recent quarterly result showed an EPS loss that beat analyst expectations (smaller loss than forecast), which is a constructive data point for the stock’s narrative as it tries to prove operating traction. (Company/earnings background)
  • Neutral Sentiment: Micron’s strong clarification on HBM4 production lifted parts of the semiconductor/tech complex early in the session, a sector-level item that can sometimes help small tech hardware names—but it’s not directly tied to Movano’s business. Market Movers: Micron Soars on CFO Comments
  • Neutral Sentiment: Morning notes suggested U.S. futures could bounce, indicating intraday volatility rather than a durable trend—small caps like MOVE often amplify these swings. U.S. Stocks May Move Back To The Upside In Early Trading
  • Neutral Sentiment: Broader risk sentiment is also being shaped by crypto and macro commentary (e.g., Grayscale’s view of Bitcoin behaving like a growth asset), which matters for market risk appetite but is an indirect influence on Movano. Is Bitcoin Digital Gold or Growth Asset? Grayscale Weighs In
  • Negative Sentiment: Major U.S. averages slid sharply on renewed AI disruption worries; a tech‑led pullback drags speculative and micro‑cap tech stocks harder, putting direct downward pressure on MOVE. U.S. Stocks Move Sharply Lower Amid AI Disruption Concerns
  • Negative Sentiment: Stronger-than-expected U.S. jobs data and related risk‑off moves hit risk assets (crypto and small caps), a macro headwind for cash‑burning tech businesses with minimal revenue. Bitcoin, Ethereum, XRP, Dogecoin Slide As Strong Jobs Data Sparks Risk-Off Move
  • Negative Sentiment: Geopolitical/tech regulatory headlines (e.g., Russia blocking WhatsApp/pressure on Meta) add to negative sentiment for the broader tech complex and investor caution toward speculative names. Russia blocks Meta’s WhatsApp messaging service

Wall Street Analyst Weigh In

Several research analysts have commented on the stock. Wall Street Zen raised shares of Movano from a “sell” rating to a “hold” rating in a report on Saturday, February 7th. Weiss Ratings reiterated a “sell (e+)” rating on shares of Movano in a research report on Thursday, January 22nd. One investment analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, the company has an average rating of “Sell”.

Check Out Our Latest Report on MOVE

Movano Stock Performance

Shares of NASDAQ:MOVE traded down $1.08 on Thursday, reaching $12.48. The company’s stock had a trading volume of 149,522 shares, compared to its average volume of 2,055,455. The company has a 50-day simple moving average of $10.09 and a 200 day simple moving average of $8.44. Movano has a 52-week low of $4.67 and a 52-week high of $54.40. The company has a market cap of $14.23 million, a P/E ratio of -1.15 and a beta of 0.81.

Movano (NASDAQ:MOVEGet Free Report) last announced its quarterly earnings results on Friday, November 14th. The technology company reported ($4.73) EPS for the quarter, beating analysts’ consensus estimates of ($7.00) by $2.27. The firm had revenue of $0.08 million during the quarter, compared to the consensus estimate of $3.88 million. Movano had a negative net margin of 3,409.60% and a negative return on equity of 647.91%.

Movano Company Profile

(Get Free Report)

Movano Health, Inc (NASDAQ: MOVE) is a health technology company focused on developing wearable devices for continuous biometric monitoring. The company’s core mission is to provide accessible, real-time health insights through noninvasive sensors, enabling individuals and care teams to track vital signs and physiological trends outside of traditional clinical settings.

Movano’s flagship product is a biometric monitoring ring designed to measure parameters such as heart rate, blood oxygen saturation, skin temperature, and sleep quality.

Further Reading

Receive News & Ratings for Movano Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Movano and related companies with MarketBeat.com's FREE daily email newsletter.